Brickell Biotech Stock
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Sign up today and learn more about Brickell Biotech Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Brickell Biotech Stock
Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.
Co-Founder and President
President and Chief Scientific Officer
Chief Financial Officer
Vice President, New Product Development
Vice President, Product Development
Vice President, Chemistry, Manufacturing, and Controls
Co-Founder and Vice President, Operations
Senior Vice President, Global Regulatory Affairs
Business Wire (press release) - Oct, 24 2017Brickell Biotech Announces Positive Phase 2b Study Results for BBI-4000 (Sofpironium Bromide) in Subjects with ...
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase